Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Sigbjørn Berentsen, Ulla Randen, Anne Marita Vågan, et al.
Blood (2010) Vol. 116, Iss. 17, pp. 3180-3184
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Blood (2014) Vol. 124, Iss. 19, pp. 2930-2936
Open Access | Times Cited: 309
Cold agglutinin disease
Paul Swiecicki, Livia Hegerova, Morie A. Gertz
Blood (2013) Vol. 122, Iss. 7, pp. 1114-1121
Open Access | Times Cited: 289
Treatment of autoimmune hemolytic anemias
Alberto Zanella, Wilma Barcellini
Haematologica (2014) Vol. 99, Iss. 10, pp. 1547-1554
Open Access | Times Cited: 243
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 395-411
Open Access | Times Cited: 215
How I treat autoimmune hemolytic anemia
Ronald S. Go, Jeffrey L. Winters, Neil E. Kay
Blood (2017) Vol. 129, Iss. 22, pp. 2971-2979
Open Access | Times Cited: 174
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D’Sa, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 14, pp. 1323-1334
Open Access | Times Cited: 156
Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
Sigbjørn Berentsen, Geir E. Tjønnfjord
Blood Reviews (2012) Vol. 26, Iss. 3, pp. 107-115
Open Access | Times Cited: 185
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Ulla Randen, Gunhild Trøen, Anne Tierens, et al.
Haematologica (2013) Vol. 99, Iss. 3, pp. 497-504
Open Access | Times Cited: 162
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 287-293
Open Access | Times Cited: 153
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
Meletios Α. Dimopoulos, Efstathios Kastritis, Roger G. Owen, et al.
Blood (2014) Vol. 124, Iss. 9, pp. 1404-1411
Open Access | Times Cited: 151
TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins
Ju Shi, Eileen L. Rose, Andrew Singh, et al.
Blood (2014) Vol. 123, Iss. 26, pp. 4015-4022
Open Access | Times Cited: 141
Autoimmune hemolytic anemia
Anita Hill, Quentin A. Hill
Hematology (2018) Vol. 2018, Iss. 1, pp. 382-389
Open Access | Times Cited: 135
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Blood (2012) Vol. 119, Iss. 16, pp. 3691-3697
Open Access | Times Cited: 126
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
Classification and therapeutic approaches in autoimmune hemolytic anemia: an update
Marc Michel
Expert Review of Hematology (2011) Vol. 4, Iss. 6, pp. 607-618
Closed Access | Times Cited: 122
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
Blood (2017) Vol. 130, Iss. 4, pp. 537-541
Open Access | Times Cited: 113
The Changing Landscape of Autoimmune Hemolytic Anemia
Wilma Barcellini, Bruno Fattizzo
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 109
Cold agglutinin disease
Sigbjørn Berentsen
Hematology (2016) Vol. 2016, Iss. 1, pp. 226-231
Open Access | Times Cited: 101
How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, et al.
Blood (2018) Vol. 133, Iss. 9, pp. 893-901
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top